The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
L | Antineoplastic and immunomodulating agents | |
2
|
L01 | Antineoplastic agents | |
3
|
L01C | Plant alkaloids and other natural products | |
4
|
L01CD | Taxanes | |
5
|
L01CD01 | Paclitaxel |
| Active Ingredient |
|---|
|
Paclitaxel is an antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilises microtubules by preventing depolymerisation. This stability results in the inhibition of the normal dynamic reorganisation of the microtubule network that is essential for vital interphase and mitotic cellular functions. |
| Document | Type | Information Source | |
|---|---|---|---|
| ABRAXANE Powder for suspension for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| ANZATAX Concentrate for solution for injection | MPI, EU: SmPC | Pharmaceutical Benefits Scheme (AU) | |
| APEALEA Powder for solution for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| EBETAXEL Concentrate for solution for infusion | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| NAVERUCLIF Powder for dispersion for infusion | MPI, EU: SmPC | European Medicines Agency (EU) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.